Legend Biotech (LEGN) Other Operating Expenses (2020 - 2025)

Legend Biotech's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$970000.0 for Q1 2025.

• Quarterly Other Operating Expenses changed N/A year-over-year to -$970000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$970000.0 (down 21830.82% YoY) and the FY2024 annual result came in at -$4423.0, changed N/A from the prior year.
• Other Operating Expenses was -$970000.0 for Q1 2025 at Legend Biotech, down from -$4423.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $40000.0 in Q3 2021 and bottomed at -$970000.0 in Q1 2025.
• A 3-year average of -$311474.3 and a median of -$4423.0 in 2024 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 300.0% in 2021, while the deepest fall reached 300.0% in 2021.
• Legend Biotech's Other Operating Expenses stood at $40000.0 in 2021, then slumped by 111.06% to -$4423.0 in 2024, then plunged by 21830.82% to -$970000.0 in 2025.
• Business Quant data shows LEGN's Other Operating Expenses at -$970000.0 in Q1 2025, -$4423.0 in Q4 2024, and $40000.0 in Q3 2021.